Clinical trial · Observational
Non-small Cell Lung Cancer and Quality of Life
Treatment of Non-small Cell Lung Cancer -Effects on Quality of Life and Symptom Control
NCT00818402CI-TRIAL-00018073SILKEcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Non-small cell lung cancer patients
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with verified NSCLC * after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy * Finnish speaking patients * aged 18 years or more * Written informed consent has to be signed Exclusion Criteria: * Patients not consenting to participate in the study * patients not able to communicate sufficiently * cancer type is other than non-small-cell lung cancer
References
Publications (0)
Data not yet available
No reference posted for this study.